﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/aster-dm-healthcare-posts-q1-fy25-pat-at-rs-74-cr-15962</loc><lastmod>2024-08-02T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/dabur-q1-fy25-consolidated-net-profit-up-8-at-rs-500-cr-15963</loc><lastmod>2024-08-02T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sun-pharma-posts-q1-fy25-consolidated-pat-at-rs-283562-cr-15964</loc><lastmod>2024-08-02T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/glaxosmithkline-pharmaceuticals-reports-q1-fy25-pat-at-rs-182-cr-15965</loc><lastmod>2024-08-02T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>